Head of CMC
Bruce Weaver is the head of CMC at Orange Grove Bio. Bruce has over 20 years experience in early phase clinical process development and clinical manufacturing of recombinant proteins. Bruce led CMC programs in vaccines (VaxInnate), fusion proteins, (Torque), biosimilars (Kashiv) as well as mAbs in a CMO environment (Laureate). Project scope spans from cell line development to fill finish. Bruce received his undergraduate degree in Chemical Engineering from Bucknell University, and holds Masters Degrees from Tufts University and Rutgers University.